by Lisa Nadal | Jul 4, 2023 | Press Releases
The study was conducted by scientists at Philochem AG, the wholly owned Swiss subsidiary company of the Philogen group. The paper can be accessed on the Nature Chemistry website at the following link. Nat_chem_280223_press_releaseby Lisa Nadal | May 12, 2023 | Past Events
Dr. Ettore Gilardoni (Head of Bio-MS) will present a poster entitled: Proteomic analysis reveals insights into the mechanism of the Intra-cork approach for increasing therapeutic window of immunocytokines Domenico Ravazza, (1st year PhD Student), will present a poster...by Lisa Nadal | Mar 16, 2023 | Past Events
Prof. Dr. Dario Neri (CEO and CSO), Dr. Covelli (CMO), Dr. Dakhel, Dr. De Luca, Dr. Cazzamalli, Dr. Galbiati, Dr. Puca, Sara Puglioli. Matilde Bocci, Giulia Rotta, Eleonora Prodi and Aureliano Zana will participate at the event. Moreover, the following abstracts have...by Lisa Nadal | Mar 16, 2023 | Past Events
Prof. Dario Neri (CEO and CSO), and Emanuele Puca (Investor Relations) will participate at the event to present Philogen and its programs to the financial community.by Lisa Nadal | Mar 16, 2023 | Past Events
Dr. Covelli (CMO), Dr. Elia, Dr. Ravenni, and Dr. Nadal will participate at the event in Rome. The dermato-oncology team from St. Gallen will give a presentation entitled “Intralesional administration of L19IL2/L19TNF in difficult-to-treat BCC patients shows favorable...
Recent Comments